With multiple novel therapies expected and the treatment paradigm shifting toward earlier intervention, the market will grow ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a clinical study ...

Dupilumab may provide a nonsteroidal option for managing cancer therapy-related skin toxicities, according to a study.

Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Regeneron has received a second complete response letter from the FDA for odronextamab and anticipates delays for Eylea HD ...

On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% ...

This study could potentially impact the stock performance of Regeneron Pharmaceuticals and Sanofi, as positive results may enhance investor sentiment and market valuation. The study’s focus on COPD, a ...

Dupilumab resolves severe skin reactions and reduces treatment discontinuation rates in a study.

A superior court judge in Bergen County Friday denied former Student Athlete Academy trainer Donald Davis’s request to be released from jail as he awaits separate trials for aggravated criminal ...

The capital murder trial for a man accused of killing a person outside a Fayetteville McDonald's began Monday. Keyvon Tah'lil Jarrett, 25, is accused of shooting and killing Edwin Swan, 28, in 2022.